By Michael Quigley, VP of Market Research, LSN
LSN’s, Redefining Early Stage Investments conference series, is back in Boston for its 10th conference. The RESI team has produced a content rich agenda featuring over 75 investors on 18 different panels, and 5 educational workshop sessions. Investors from family offices, top tier VC’s, large pharma/medical technology firms, angels will be shedding light regarding their process of making investment decisions and what early stage companies should be doing to stand out from the crowd.
RESI Boston also represents an amazing geographic diversity with investors hailing from North America, Europe and Asia all with a common goal of sourcing early stage assets. There will be a new Asia-North America Investor Track that will feature a total of 15 different speakers representing Japan, Korea and China based firms looking to make investments across the pacific. The broad strategy of these Asian based investors is simple – identify compelling assets for their dynamic markets.
The agenda below represents the current early-stage healthcare investment landscape and how it has adapted to serve this evolving industry. Click on any image below to see the full speaker lineup for yourself and to decide who you will be listening to come September 13th.
|Track 1: Therapeutics Investor Panels||Track 2: Device, Diagnostic, and HCIT Investor Panels||Track 3: Early Stage Workshops|
|Track 1: Therapeutics Investor Panels||Track 2: Device, Diagnostic, and HCIT Investor Panels||Track 4: Asia-North America Panels|